504 related articles for article (PubMed ID: 6889533)
21. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
Butkerait P; Friedman E
Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
[TBL] [Abstract][Full Text] [Related]
22. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.
Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):153-64. PubMed ID: 6137027
[TBL] [Abstract][Full Text] [Related]
23. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
Bernardi MM; Palermo-Neto J
Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
25. Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Adv Biochem Psychopharmacol; 1982; 31():341-6. PubMed ID: 6123224
[No Abstract] [Full Text] [Related]
26. Antagonism by sulpiride of three apomorphine-induced effects in rodents.
Puech AJ; Simon P; Boissier JR
Eur J Pharmacol; 1976 Apr; 36(2):439-41. PubMed ID: 945169
[TBL] [Abstract][Full Text] [Related]
27. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
Van Hest A; van Haaren F; van de Poll NE
Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
[TBL] [Abstract][Full Text] [Related]
28. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
Wambebe C
Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
[TBL] [Abstract][Full Text] [Related]
29. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
Georgiev V; György L; Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
[TBL] [Abstract][Full Text] [Related]
30. Effects of single and long-term administration of sulpiride on open-field and stereotyped behavior of rats.
Frussa-Filho R; Palermo-Neto J
Braz J Med Biol Res; 1990; 23(5):463-72. PubMed ID: 2095296
[TBL] [Abstract][Full Text] [Related]
31. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
32. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
[TBL] [Abstract][Full Text] [Related]
33. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
[TBL] [Abstract][Full Text] [Related]
34. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
Waddington JL; Gamble SJ
Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
[TBL] [Abstract][Full Text] [Related]
36. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
Pierce RC; Rowlett JK; Bardo MT; Rebec GV
Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
[TBL] [Abstract][Full Text] [Related]
37. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
Lipska BK; Weinberger DR
Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
[TBL] [Abstract][Full Text] [Related]
38. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
[TBL] [Abstract][Full Text] [Related]
39. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
Hasan F; Leonard BE
Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
[No Abstract] [Full Text] [Related]
40. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD
Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
